Figure 1 (Chemical Structure)
Sevelamer Hydrochloride
Product Images NDC 0955-5902
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sevelamer Hydrochloride (NDC 0955-5902). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Sevelamerhcl 02)
This appears to be a chart displaying the percentage of patients with reduction in serum phosphorus levels using an active control, Sevelamer Hydrochloride. The chart indicates the reduction from baseline as well as whether the condition worsened or improved. The X axis shows the reduction in serum phosphorus levels in mg/dL, while the Y axis shows the percentage of patients with reduction greater than X.*
Figure 3 (Sevelamerhcl 03)
Not available.*
Principal Display Panel (800 mg Tablet Bottle Label)
This is a description of Sevelamer Hydrochloride Tablets. Each tablet contains 800 mg of Sevelamer hydrochloride and inactive ingredients such as Hypromellose, diacetylated monoglyceride, colloidal silicon dioxide, and stearic acid. It is manufactured by Winthrop, a Sanofi company. The 180 tablets are for the usual dose, which can be found on the package insert. It is recommended to store it at 25°C (77°F) in a tight container, protected from moisture. The NDC number is 0955-1048-18, and it should only be dispensed with a prescription.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
